The COX and 5-LOX pathways play major roles in epilepsy-related neuroinflammation, and COX inhibitors and montelukast, which are inhibitors of each pathway, respectively, are known to have anti-epileptic effects (Dhir, 2019; Tesfaye et al., 2021). The gene discussed is ALOX5; the disease is epilepsy.